It wont be completed by next year, management have said it'll...

It wont be completed by next year, management have said it'll take 12 months to ramp up the trial centres in all regions after sequential applications, before the 240 enrolment alone, and then study interpretation/results readout occurring in 2024-2025.

Its confirmed as that in the MST financial report also, with a readout date of 2025 for P3 catalysts.

I believe that there may be a subset of that 240 patients, say a hypothetical random number of 40 patients , who are going through the first region via Australian trial centres that commences in June 2022 and finishes next year. But for the EU/UK/US trial centres applications, enrolment and all going online, will take 12-24 months longer.

So the dates aren't incorrect on clinicaltrialsgov, but it may be picking up the dates from the first region being Australia, rather than the other 3 trial centre regions, which will be sequentially going online.

Given this data may be routed from the Australian CTA, this would make sense.

All in my opinion/speculation.